Gisbert Schneider

individual

Ecosystem influencer

About

Gisbert Schneider is a German-Swiss biochemist and bioinformatician best known for AI-driven drug discovery and computer-assisted molecular design at ETH Zurich. He is a professor at ETH Zurich and a prominent scientific voice in generative AI for pharmaceuticals, with recognition including the Prous Institute’s Overton & Meyer Award. Public sources also link him to biotech entrepreneurship, including co-founding inSili.com and Endogena Therapeutics, and serving as CEO of Xanadys GmbH.

Areas of interest

AIdrug discoverycomputational chemistrymedicinal chemistrybiotechregenerative medicineophthalmologymachine learning